Business Alexander Labrunerie Reduces Amgen Stake to $247,000 Amid Market Changes Alexander Labrunerie & CO. Inc. has reduced its stake in Amgen Inc. (NASDAQ: AMGN) by 7.6% during the second quarter, according to the firm’s... Editorial12 hours ago